Profile of Anaphylactic Reaction in Surabaya from January 2014 to May 2018
Methods: This study was a cross-sectional and retrospective study by assessing patients’ medical records and was analyzed descriptively.
Results: 22 patients were identified as anaphylactic reaction. The prevalence of anaphylactic reaction from year to year cannot be identified surely because of underdiagnose and underreporting. The most common cause of anaphylactic reaction in Dr. Soetomo General Hsopital was drugs (50%). The most drugs were antibiotics (22.73%) and the most antibiotics were groups of penicillin (40%) and cephalosporin (40%). The most common clinical manifestation was skin-related (77.27%), which includes urticaria (4.55%), angioedem (27.27%), pruritus (27.27%) cold skin (0.09%), pallor (4.55%), and cyanosis (4.55%). Most patients became better (45.54%) after getting treatment from the doctor.
Conclusion: The most common cause of anaphylactic reaction was drugs, the most drugs were antibiotics and the most antibiotics were groups of penicillin and cephalosporin. The most clinical manifestation was skin-related. Most of anaphylactic reaction’s patients became better after getting treatment from the doctor. Underdiagnose and underreporting are the problem often encountered in cases of anaphylactic reaction.
Thong BYH and Tan T-C. Epidemiology and Risk Factors for Drug Allergy. Br J Clin Pharmacol. 2011; 71: 684-700.
Dhami S, Sheikh A, Muraro A, et al. Quality Indicators for the Acute and Long-Term Management of Anaphylaxis: A Systematic Review. Clinical and Translational Allergy. 2017; 7: 15.
Kim SY, Kim MH and Cho YJ. Different Clinical Features of Anaphylaxis according to Cause and Risk Factors for Severe Reactions. Allergology International : Official Journal of the Japanese Society of Allergology. 2018; 67: 96-102.
Wawrzyniak P, Akdis CA, Finkelman FD and Rothenberg ME. Advances and Highlights in Mechanisms of Allergic Disease in 2015. The Journal of Allergy and Clinical Immunology. 2016; 137: 1681-96.
Park HK, Kang MG, Yang MS, Jung JW, Cho SH and Kang HR. Epidemiology of Drug-Induced Anaphylaxis in a Tertiary Hospital in Korea. Allergology International : Official Journal of the Japanese Society of Allergology. 2017; 66: 557-62.
Jerschow E, Lin RY, Scaperotti MM and McGinn AP. Fatal Anaphylaxis in the United States, 1999-2010: Temporal Patterns and Demographic Associations. The Journal of Allergy and Clinical Immunology. 2014; 134: 1318-28.e7.
Simons FE. Anaphylaxis: Recent Advances in Assessment and Treatment. The Journal of Allergy and Clinical Immunology. 2009; 124: 625-36; quiz 37-8.
Tejedor-Alonso MA, Moro-Moro M and Múgica-García MV. Epidemiology of Anaphylaxis: Contributions From the Last 10 Years. Journal of Investigational Allergology & Clinical Immunology. 2015; 25: 163-75; quiz follow 74-5.
Afify SM and Pali-Schöll I. Adverse Reactions to Food: The Female Dominance - A Secondary Publication and Update. World Allergy Organ J. 2017; 10: 43-.
Liew WK, Williamson E and Tang ML. Anaphylaxis Fatalities and Admissions in Australia. The Journal of Allergy and Clinical Immunology. 2009; 123: 434-42.
Legendre DP, Muzny CA, Marshall GD and Swiatlo E. Antibiotic Hypersensitivity Reactions and Approaches to Desensitization. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2014; 58: 1140-8.
Bhattacharya S. The Facts about Penicillin Allergy: A Review. J Adv Pharm Technol Res. 2010; 1: 11-7.
Justiz Vaillant AA and Zito PM. Immediate Hypersensitivity Reactions. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC., 2020
Copyright (c) 2020 Amalia Putri Uswatun Hasanah, Ari Baskoro, Pesta Parulian Maurid Edwar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).